Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers
Open Access
- 15 July 2020
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (1) , 186-197
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK119576‐01A1)
This publication has 38 references indexed in Scilit:
- A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease TreatmentsPLOS Medicine, 2012
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011
- Surveillance Protocol Kidney Transplant Biopsies: Their Evolving Role in Clinical PracticeAmerican Journal of Transplantation, 2011
- Outpatient versus Inpatient Observation after Percutaneous Native Kidney Biopsy: A Cost Minimization StudyAmerican Journal of Nephrology, 2011
- Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and CorrelationsAmerican Journal of Transplantation, 2009
- Acute Antibody-Mediated Rejection in Living ABO-Incompatible Kidney Transplantation: Long-Term Impact and Risk FactorsAmerican Journal of Transplantation, 2009
- The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled StudyAmerican Journal of Transplantation, 2008
- Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney TransplantationAmerican Journal of Transplantation, 2007
- Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized StudyAmerican Journal of Transplantation, 2007
- Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney TransplantsTransplantation, 2006